118 related articles for article (PubMed ID: 7621433)
1. Temperature monitoring during photodynamic therapy of skin tumors with topical 5-aminolevulinic acid application.
Orenstein A; Kostenich G; Tsur H; Kogan L; Malik Z
Cancer Lett; 1995 Jul; 93(2):227-32. PubMed ID: 7621433
[TBL] [Abstract][Full Text] [Related]
2. [Photodynamic diagnosis and therapy of neoplasms of the facial skin after topical administration of 5-aminolevulinic acid].
Lang S; Baumgartner R; Struck R; Leunig A; Gutmann R; Feyh J
Laryngorhinootologie; 1995 Feb; 74(2):85-9. PubMed ID: 7710611
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of the superficial perfusion and temperature in connection with photodynamic therapy of basal cell carcinomas using esterified and non-esterified 5-aminolaevulinic acid.
Pålsson S; Gustafsson L; Bendsoe N; Soto Thompson M; Andersson-Engels S; Svanberg K
Br J Dermatol; 2003 Jun; 148(6):1179-88. PubMed ID: 12828747
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application.
Orenstein A; Haik J; Tamir J; Winkler E; Trau H; Malik Z; Kostenich G
Dermatol Surg; 2000 Aug; 26(8):765-9; discussion 769-70. PubMed ID: 10940064
[TBL] [Abstract][Full Text] [Related]
5. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
[TBL] [Abstract][Full Text] [Related]
6. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
Harth Y; Hirshovitz B
Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
[TBL] [Abstract][Full Text] [Related]
7. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
Itkin A; Gilchrest BA
Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.
Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P
Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345
[TBL] [Abstract][Full Text] [Related]
9. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma.
Kuijpers DI; Thissen MR; Thissen CA; Neumann MH
J Drugs Dermatol; 2006; 5(7):642-5. PubMed ID: 16865869
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine.
Fijan S; Hönigsmann H; Ortel B
Br J Dermatol; 1995 Aug; 133(2):282-8. PubMed ID: 7547399
[TBL] [Abstract][Full Text] [Related]
11. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage.
Touma D; Yaar M; Whitehead S; Konnikov N; Gilchrest BA
Arch Dermatol; 2004 Jan; 140(1):33-40. PubMed ID: 14732657
[TBL] [Abstract][Full Text] [Related]
12. Daylight-mediated photodynamic therapy of basal cell carcinomas - an explorative study.
Wiegell SR; Skødt V; Wulf HC
J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):169-75. PubMed ID: 23294223
[TBL] [Abstract][Full Text] [Related]
13. Plum-blossom needling enhanced the effect of photodynamic therapy on basal cell carcinoma.
Mu X; Wang L; Wang L; Ge R; Dang H; Mou K
Photodiagnosis Photodyn Ther; 2018 Sep; 23():339-341. PubMed ID: 30077651
[TBL] [Abstract][Full Text] [Related]
14. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A
Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.
Morton CA; Brown SB; Collins S; Ibbotson S; Jenkinson H; Kurwa H; Langmack K; McKenna K; Moseley H; Pearse AD; Stringer M; Taylor DK; Wong G; Rhodes LE
Br J Dermatol; 2002 Apr; 146(4):552-67. PubMed ID: 11966684
[TBL] [Abstract][Full Text] [Related]
16. Green light is effective and less painful than red light in photodynamic therapy of facial solar keratoses.
Fritsch C; Stege H; Saalmann G; Goerz G; Ruzicka T; Krutmann J
Photodermatol Photoimmunol Photomed; 1997; 13(5-6):181-5. PubMed ID: 9542754
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma.
Morton CA; Whitehurst C; McColl JH; Moore JV; MacKie RM
Arch Dermatol; 2001 Mar; 137(3):319-24. PubMed ID: 11255332
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of photodynamic therapy of skin cancers with partial differential alpha-aminolevulinic acid.
Xu S; Wang X; Xu W; Xia Y; Zhang C
Chin Med J (Engl); 2002 Aug; 115(8):1141-5. PubMed ID: 12215278
[TBL] [Abstract][Full Text] [Related]
19. Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source.
Varma S; Wilson H; Kurwa HA; Gambles B; Charman C; Pearse AD; Taylor D; Anstey AV
Br J Dermatol; 2001 Mar; 144(3):567-74. PubMed ID: 11260016
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
